Arecor Therapeutics PLC Appoints David Ellam as Interim Chief Financial Officer to Succeed Susan Lowther
Position
Chief Financial Officer
Company
Arecor Therapeutics PLC
CambridgeBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Arecor Therapeutics PLC has announced the appointment of David Ellam as its interim chief financial officer, effective immediately. This appointment comes following the resignation of Susan Lowther, the company's first CFO, in April. The CEO, Sarah Howell, expressed confidence in Ellam's extensive finance and life sciences knowledge, emphasizing the value he will bring in supporting the company's strategic initiatives and driving shareholder value.
Quick answer
Arecor Therapeutics PLC Appoints David Ellam as Interim Chief Financial Officer to Succeed Susan Lowther (November 18, 2024). Arecor Therapeutics PLC is based in Cambridge, England, United Kingdom.
- Who is the new Chief Financial Officer at Arecor Therapeutics PLC?
- Arecor Therapeutics PLC named David Ellam Chief Financial Officer, announced November 18, 2024.
- What did Arecor Therapeutics PLC announce on November 18, 2024?
- Arecor Therapeutics PLC has announced the appointment of David Ellam as its interim chief financial officer, effective immediately. This appointment comes following the resignation of Susan Lowther, the company's first CFO, in April.
- What does Arecor Therapeutics PLC do?
- Arecor Therapeutics PLC is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products.
- Where is Arecor Therapeutics PLC based?
- Arecor Therapeutics PLC is based in Cambridge, England, United Kingdom.
- Which similar companies made leadership changes around the same time?
- NRx Pharmaceuticals (November 18, 2024), BerGenBio ASA (November 20, 2024), Tarsus Pharmaceuticals (November 5, 2024) and TORL BioTherapeutics (December 2, 2024) also announced leadership changes within 45 days of Arecor Therapeutics PLC.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- NRx Pharmaceuticals Appoints Michael Abrams as Chief Financial Officer (November 18, 2024)
- BerGenBio Appoints Olav Hellebø as CEO (November 20, 2024)
- Tarsus Pharmaceuticals Appoints Dr. Elizabeth Yeu, M.D., as Chief Medical Officer (November 5, 2024)
- TORL BioTherapeutics Appoints Aran Maree, MD, as Chief Medical Officer and Initiates Global Phase 2 Study of TORL-1-23 (December 2, 2024)
- Alkeus Pharmaceuticals Appoints David Arkowitz as Chief Financial Officer (October 31, 2024)
- Byondis Appoints Louis Denis, M.D. as Chief Medical Officer (November 19, 2024)
Who to call at Arecor Therapeutics PLC, and when
A new leader at Arecor Therapeutics PLC brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Arecor Therapeutics PLC raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Arecor Therapeutics PLC, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Arecor Therapeutics PLC. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Arecor Therapeutics PLC changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Arecor Therapeutics PLC changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.